Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction

Edward Wilson,Jacob Umans,Michelle Swarovski,Paras Minhas,Øivind Midttun,Arve Arve Ulvik,Marian Shahid-Besanti,Patricia Linortner,Siddhita Mhatre,Qian Wang,Divya Channappa,Nicole Corso,Lu Tian,Carolyn Fredericks,Geoffrey Kerchner,Edward Plowey,Brenna Cholerton,Per Ueland,Cyrus Zabetian,Nora Gray,Joseph Quinn,Thomas Montine,Sharon Sha,Frank Longo,David Wolk,Alice Chen-Plotkin,Victor Henderson,Tony Wyss-Coray,Anthony Wagner,Elizabeth Mormino,Nima Aghaeepour,Kathleen Poston,Katrin Andreasson

DOI: https://doi.org/10.21203/rs.3.rs-4980210/v1

2024-09-26

Abstract:Parkinson's disease (PD) is a complex multisystem disorder clinically characterized by motor, non-motor, and premotor manifestations. Pathologically, PD involves neuronal loss in the substantia nigra, striatal dopamine deficiency, and accumulation of intracellular inclusions containing aggregates of α-synuclein. Recent studies demonstrate that PD is associated with dysregulated metabolic flux through the kynurenine pathway (KP), in which tryptophan is converted to kynurenine (KYN), and KYN is subsequently metabolized to neuroactive compounds quinolinic acid (QA) and kynurenic acid (KA). This multicenter study used highly sensitive liquid chromatography-tandem mass-spectrometry to compare blood and cerebral spinal fluid (CSF) KP metabolites between 158 unimpaired older adults and 177 participants with PD. Results indicate that increased neuroexcitatory QA/KA ratio in both plasma and CSF of PD participants associated with peripheral and cerebral inflammation and vitamin B6 deficiency. Furthermore, increased QA tracked with CSF tau and severity of both motor and non-motor PD clinical dysfunction. Importantly, plasma and CSF kynurenine metabolites classified PD participants with a high degree of accuracy (AUC = 0.897). Finally, analysis of metabolite data revealed subgroups with distinct KP profiles, and these were subsequently found to display distinct PD clinical features. Together, these data further support the hypothesis that the KP serves as a site of brain and periphery crosstalk, integrating B-vitamin status, inflammation and metabolism to ultimately influence PD clinical manifestation.